Patent Licensing Risks in Technology Commercialization Deals
Patent licensing can turn a technical asset into revenue, market access or a strategic partnership. It can also weaken an investor's thesis if the licence is vague, unrecorded or misaligned with the product roadmap. For a founder, investor or acquirer, the question is whether the licensing structure connects the patent register, the agreement and the business plan.
Why This Matters
The statutory starting point is the Patents Act, 1970. Section 48 gives the patentee exclusive rights in relation to patented products and processes, while sections 68 to 70 make written instruments, register entries and the powers of a registered grantee or proprietor central to title and dealing with the patent.
That matters because the licence is often treated as a commercial shortcut. A startup may license university-developed technology, a group company may hold patents for operating subsidiaries, or a product company may grant a field-limited licence to a manufacturing partner. Each structure works only if the grant matches the intended product, territory, field, channel and revenue model.
Investors should also watch section 140, which addresses certain restrictive conditions in patent-related contracts, and the compulsory licensing framework in Chapter XVI. These provisions do not make every commercial restriction invalid, but counsel should review licence controls instead of assuming that exclusivity, non-challenge language, tie-ins or field restrictions will work as drafted.
What Counsel Should Review
Start with the patent asset. Counsel should check the application or patent number, owner, status, term, renewal position, assignments, recorded interests and register entries. IP India's public patent search and Patent E-Register are practical starting points, supported by the Patents Rules, 2003 and the Patent Office manual.
Then test the grant. The agreement should say whether the licence is exclusive, sole or non-exclusive; whether it covers making, using, selling, offering for sale or importing; whether it applies to a product, component, process, platform or improvement; and whether it is limited by territory, field of use, customer segment or channel.
Sublicensing and group-company use need separate attention. A licence to one operating entity may not automatically cover affiliates, contract manufacturers, distributors or future acquisition vehicles. If commercialization depends on a broader ecosystem, the agreement should permit it expressly.
Royalty mechanics should be audit-ready. Counsel should review the royalty base, net sales deductions, minimum commitments, milestone payments, withholding, reporting cadence, audit rights and consequences of underreporting. A royalty clause that cannot be reconciled against invoices is a diligence problem.
The review should also cover enforcement. Section 109 recognizes the right of an exclusive licensee to take infringement proceedings in specified circumstances. The agreement should allocate who controls enforcement, who funds it, who settles, how recoveries are shared and whether the licensee can respond to third-party challenges.
Finally, counsel should check recordal steps. IP India's forms and official fees materials include patent register entries, and recordal evidence may matter during diligence, enforcement or an exit. The transaction file should preserve executed licences, approvals, filings and Patent Office correspondence.
How Findings Affect The Deal
A clean patent licence can support revenue quality and product defensibility. A weak one can shift value away from the funded company. Red flags include unsigned grants, unclear field scope, missing sublicensing rights, royalty terms that break under channel sales, conflicting exclusivity and termination rights that can remove core technology after closing.
For investors and acquirers, findings should flow into transaction documents. The deal team may need licence-specific warranties, disclosure schedules, consent conditions, recordal covenants, indemnities or a closing condition tied to confirming the patent register.
Typical Timeline and Cost Range
A focused patent licensing review for one patent family and one agreement can often be scoped within 1-2 weeks once the licence, register extracts, prosecution details and revenue model are available. A deeper review involving several patent families, group-company grants or universities may take 3-5 weeks and may require patent-agent input.
The review should be staged: confirm patent status and owner, map the grant to the business model, then resolve recordal, exclusivity, sublicensing, enforcement and termination issues before signing or closing.
Common Mistakes
- Licensing a patent without checking register evidence. The agreement may look complete, but investors still need to verify owner, status, assignments, recorded interests and pending recordal steps.
- Using broad exclusivity without field discipline. Exclusivity should match the actual product, territory, customer segment and commercialization plan, not block future use that the business still needs.
- Ignoring enforcement and challenge control. A licence should state who can sue, defend, settle, fund proceedings and manage patent validity challenges.
How KAS & Co. Can Help
KAS & Co. helps investors, acquirers and technology companies review patent licences, commercialization structures, recordal evidence and transaction risk allocation. For a focused review before funding, acquisition or licensing negotiations, contact KAS & Co..
FAQs
1. Does every patent licence need to be recorded in India?
Recordal should be reviewed for each deal. Sections 68 to 70 make written instruments and register entries important, and investors should ask counsel to confirm the correct filing path and evidence needed.
2. What is the difference between an exclusive and non-exclusive patent licence?
An exclusive licence gives stronger commercial control to one licensee within the agreed scope, while a non-exclusive licence allows the patent owner to license others. The answer depends on territory, field and sublicensing terms.
3. Can a licensee enforce a patent in India?
An exclusive licensee may have enforcement rights under section 109 in specified circumstances. The licence should still allocate notice, control, funding, settlement rights and recovery sharing.
4. What documents should investors request for patent licence diligence?
Ask for the executed licence, amendments, patent schedules, register extracts, assignment history, royalty reports, sublicences, enforcement correspondence and Patent Office recordal filings.
Sources
Topics
Need legal advice on this topic?
KAS & Co. provides strategic legal counsel across technology law, data privacy, IP and commercial advisory.
Schedule a Consultation